The Europe Human Identification Market would witness market growth of 10.4% CAGR during the forecast period (2023-2030).
Certain vital players' NGS technology and informatics provide substantially more information from forensic DNA than traditional PCR and capillary electrophoresis (CE) techniques and at a much higher resolution than was previously achievable. With the targeted power of NGS-based forensic genomics methodologies, leading companies assert that their customers can obtain the answers they need more quickly and with greater certainty, thereby boosting the market.
Massively parallel sequencing (MPS) and capillary electrophoresis are two popular techniques for human identification at forensic and paternity testing facilities in many developed nations. In both procedures, DNA is extracted from various materials, and portions of the DNA are evaluated to generate a genetic fingerprint for each person. The key suppliers supply capillary electrophoresis and massively parallel sequencing reagents, equipment, services, and support for quantification, DNA extraction, STR amplification, and analysis.
Major providers offer human identification products through specialist teams of former forensic DNA practitioners. They provide laboratory application training, validation of DNA analysis methodologies, equipment installation and maintenance, and workflow automation equipment.
According to the U.K. Government, the overall DNA match rate (crime scene to subject) in the United Kingdom after loading a crime scene DNA profile was 64.8% in 2021/22. Although marginally less than the previous year, it demonstrates the vitality and efficacy of the national DNA database as a tool to support the Criminal Justice System. In addition, the increasing benefits of genetic testing for the discovery of rare diseases are anticipated to lead to a rise in the adoption of genetic testing in the United Kingdom, thereby driving the growth. The government's favorable attitude and the growing advantages of genetic testing are expected to cause the regional market to expand.
The Germany market dominated the Europe Human Identification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $210.7 million by 2030. The UK market is anticipated to grow at a CAGR of 9.5% during (2023 - 2030). Additionally, The France market would witness a CAGR of 11.2% during (2023 - 2030).
Based on End User, the market is segmented into Forensic Laboratories and Research Centers, Academic & Government Institutes. Based on Product, the market is segmented into Assay Kits and Reagents, Instruments and Others. Based on Application, the market is segmented into Forensic Applications, Paternity Identification and Others. Based on Technology, the market is segmented into Polymerase Chain Reaction, Next-Generation Sequencing, Capillary Electrophoresis and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Human Identification Market is Projected to reach USD 3.1 Billion by 2030, at a CAGR of 10.6%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Promega Corporation, Hamilton Company, Bio-Rad Laboratories, Inc, Qiagen N.V, SecuriGene Technologies Inc., AutoGen Inc., InnoGenomics Technologies, LLC., Carolina Biological Supply Company, and Genetek Biopharma GmbH
By End User
By Product
By Application
By Technology
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
